Close Menu

isogenic cell lines

Thermo Fisher will market Horizon's X-MAN human haploid and diploid isogenic cell line collection. 

The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.

Expanding their relationship, the cancer drug developer will use the mutant-and-normal cell line library.

Horizon will develop X-MAN cancer models for the drug developer's therapeutic research programs.

The partners will use Horizon's cell lines to identify unique protein biomarker signatures.

Cambridge, UK-based Horizon will provide GSK with its isogenic cell lines for cancer metabolomics studies.

The drug developer will use Horizon's X-MAN technology in genotype-specific compound tests.

Horizon Discovery also plans to participate in a consortium of "top academic institutions and big pharmas" in the cancer field, a research partnership expected to expand its panel of isogenic cell lines for drug discovery.

The school aims to develop biomarkers for use in cancer diagnostics.

Horizon will use the genetic modeling technology to develop cancer-related screening products and services.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.